DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics
- PMID: 27119045
- PMCID: PMC4826949
- DOI: 10.1155/2016/6072357
DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics
Abstract
Epigenetics deals with the interactions between genes and the immediate cellular environment. These interactions go a long way in shaping up each and every person's individuality. Further, reversibility of epigenetic interactions may offer a dynamic control over the expression of various critical genes. Thus, tweaking the epigenetic machinery may help cause or cure diseases, especially cancer. Therefore, cancer epigenetics, especially at a molecular level, needs to be scrutinised closely, as it could potentially serve as the future pharmaceutical goldmine against neoplastic diseases. However, in view of its rapidly enlarging scope of application, it has become difficult to keep abreast of scientific information coming out of various epigenetic studies directed against cancer. Using this review, we have attempted to shed light on two of the most important mechanisms implicated in cancer, that is, DNA (deoxyribonucleic acid) methylation and histone modifications, and their place in cancer pathogenesis. Further, we have attempted to take stock of the new epigenetic drugs that have emerged onto the market as well as those in the pipeline that offer hope in mankind's fight against cancer.
Similar articles
-
[Epigenetics of schizophrenia: a review].Encephale. 2014 Oct;40(5):380-6. doi: 10.1016/j.encep.2014.06.005. Epub 2014 Aug 12. Encephale. 2014. PMID: 25127897 Review. French.
-
Targeting Chromatin Remodeling for Cancer Therapy.Curr Mol Pharmacol. 2019;12(3):215-229. doi: 10.2174/1874467212666190215112915. Curr Mol Pharmacol. 2019. PMID: 30767757 Free PMC article. Review.
-
Retrospective and perspective of plant epigenetics in China.J Genet Genomics. 2018 Nov 20;45(11):621-638. doi: 10.1016/j.jgg.2018.09.004. Epub 2018 Nov 6. J Genet Genomics. 2018. PMID: 30455036 Review.
-
Epigenetic Alterations in Inborn Errors of Immunity.J Clin Med. 2022 Feb 25;11(5):1261. doi: 10.3390/jcm11051261. J Clin Med. 2022. PMID: 35268351 Free PMC article. Review.
-
Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.Biochim Biophys Acta. 2014 Jul;1842(7):971-80. doi: 10.1016/j.bbadis.2014.02.006. Epub 2014 Feb 20. Biochim Biophys Acta. 2014. PMID: 24561654 Review.
Cited by
-
Epigenetic-Based Biomarkers in the Malignant Transformation of BEAS-2B Cells Induced by Coal Tar Pitch Extract.Medicina (Kaunas). 2020 Dec 29;57(1):24. doi: 10.3390/medicina57010024. Medicina (Kaunas). 2020. PMID: 33383878 Free PMC article.
-
Efficacy and Safety Profile of Histone Deacetylase Inhibitors for Metastatic Breast Cancer: A Meta-Analysis.Front Oncol. 2022 May 31;12:901152. doi: 10.3389/fonc.2022.901152. eCollection 2022. Front Oncol. 2022. PMID: 35712478 Free PMC article.
-
Early-life DNA methylation profiles are indicative of age-related transcriptome changes.Epigenetics Chromatin. 2019 Oct 8;12(1):58. doi: 10.1186/s13072-019-0306-5. Epigenetics Chromatin. 2019. PMID: 31594536 Free PMC article.
-
Developmental origins and oncogenic pathways in malignant brain tumors.Wiley Interdiscip Rev Dev Biol. 2019 Jul;8(4):e342. doi: 10.1002/wdev.342. Epub 2019 Apr 3. Wiley Interdiscip Rev Dev Biol. 2019. PMID: 30945456 Free PMC article. Review.
-
Region of interest methylation analysis: a comparison of MSP with MS-HRM and direct BSP.Mol Biol Rep. 2017 Jul;44(3):295-305. doi: 10.1007/s11033-017-4110-7. Epub 2017 Jul 4. Mol Biol Rep. 2017. PMID: 28676996
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources